Update on results of multifield conformal radiation therapy of non-small-cell lung cancer using multileaf collimated beams

Clinical Lung Cancer

Volumn 3, Issue 4, 2002, Pages 259-264

  Bhatnagar, Ajay ^a   Flickinger, John C ^a   Bahri, Sanjeev ^a   Deutsch, Melvin ^a   Belani, Chandra ^a   Luketich, James D ^a   Greenberger, Joel S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

3 Dimensional conformal radiation therapy; Chemoradiation; Esophagitis; Local control; Pneumonitis

Indexed keywords

CARBOPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; ESOPHAGITIS; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; PNEUMONIA; RADIATION BEAM; RADIATION DOSE; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0036302193     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2002.n.010     Document Type: Article

References (38)

1. Non-small cell carcinoma of the lung: Dose-time parameters
2. Optimization of radical radiotherapy with beam’s eye view techniques for non-small cell lung cancer
3. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy
4. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy stage III non-small-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11
5. Dose-effect relationships for functional local injury after lung irradiation
6. A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data
7. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury
8. Prospective prediction of postradiotherapy pulmonary function with regional pulmonary function data: Promise and pitfalls
9. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma
10. Radiation-induced lung damage in rats: The influence of fraction spacing on effect per fraction
11. Deterioration in lung function following hemithorax irradiation for pleural mesothelioma
12. Evaluation of isoeffect formulae for predicting radiation-induced lung damage
13. Repair in mouse lung for up to 20 fractions of X rays or neutrons
14. Residual radiation damage in murine lung assessed by pneumonitis
15. Repair in mouse lung after split doses of X rays
16. Is there a loss of repair capacity in mouse lungs with increasing numbers of dose fractions?
17. Radiation-induced lung damage: Dose-time-fractionation considerations
18. Late functional, biochemical and histological changes in the rat lung after fractionated irradiation to the whole thorax
19. Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer
20. Dose escalation for non-small cell lung cancer using conformal radiation therapy
21. Evaluation of objective plan-evaluation model in the three dimensional treatment of non-small cell lung cancer
22. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung
23. Development of multi-field three dimensional conformal radiotherapy of lung cancer using a total lung dose/volume histogram
24. Retrospective reconstruction of three-dimensional radiotherapy treatment plans of the thorax from two dimensional planning data
25. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis
26. A method to evaluate the impact of daily treatment variation on three-dimensional dose distributions
27. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
28. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients
29. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
30. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
31. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis
32. Results of multifield conformal radiation therapy of nonsmall-cell lung carcinoma using multileaf collimation beams
33. RTOG toxicity scoring criteria
34. Non-parametric estimation and incomplete observations
35. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
36. Regression models and life tables
37. Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer
38. Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer